Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study

Tigecycline is a vital antibiotic treatment option for infections caused by multiresistant bacteria in the intensive care unit (ICU). Acute kidney injury (AKI) is a common complication in the ICU requiring con...

Source: Critical Care - December 17, 2018 Category: Intensive Care Authors: A. Broeker, S. G. Wicha, C. Dorn, A. Kratzer, M. Schleibinger, F. Kees, A. Heininger, M. G. Kees and H. H äberle Tags: Research Source Type: research